


To provide a portfolio designed to achieve high and rising income.
| Name | % Net Assets |
|---|---|
| Pfizer | 3.5% |
| Altria | 3.1% |
| Vodafone | 2.9% |
| Zurich Financial Services | 2.4% |
| Coca-Cola | 2.4% |
| Mcdonalds | 2.4% |
| Total | 2.4% |
| British American Tobacco | 2.4% |
| Unilever | 2.3% |
| Merck & Co | 2.3% |
| Key | % Net Assets |
|---|---|
| 3.5% | |
| 3.1% | |
| 2.9% | |
| 2.4% | |
| 88.1% |
| Date | 20-Aug-2025 |
|---|---|
| NAV | 254.90p |
| Currency | GBP |
| Change | -0.20p |
| % | -0.08% |
| YTD change | 23.90p |
| YTD % | 10.35% |
| Fund Inception | 07/02/2007 |
|---|---|
| Fund Manager | Gerd Woort-Menker |
| TER | 0.93 (31-Jan-2013) |
| Minimum Investment | |
|---|---|
| Initial | £5000000 |
| Additional | £100,000 |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | 4.25% |
| Annual Mang't | 0.75% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research